These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 29073804)
1. Fabrication of self-assembled folate-biotin-quaternized starch nanoparticles as co-carrier of doxorubicin and siRNA. Li L; Tao R; Song M; Zhang Y; Chen K; Wang H; Gong R J Biomater Appl; 2017 Nov; 32(5):587-597. PubMed ID: 29073804 [TBL] [Abstract][Full Text] [Related]
2. Codelivery of DOX and siRNA by folate-biotin-quaternized starch nanoparticles for promoting synergistic suppression of human lung cancer cells. Li L; He S; Yu L; Elshazly EH; Wang H; Chen K; Zhang S; Ke L; Gong R Drug Deliv; 2019 Dec; 26(1):499-508. PubMed ID: 31033359 [TBL] [Abstract][Full Text] [Related]
4. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer. Wen ZM; Jie J; Zhang Y; Liu H; Peng LP Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938 [TBL] [Abstract][Full Text] [Related]
5. Self-organized nanoparticles based on chitosan-folic acid and dextran succinate-doxorubicin conjugates for drug targeting. Lee KD; Choi SH; Kim DH; Lee HY; Choi KC Arch Pharm Res; 2014 Dec; 37(12):1546-53. PubMed ID: 25280540 [TBL] [Abstract][Full Text] [Related]
6. Folate-decorated hydrophilic three-arm star-block terpolymer as a novel nanovehicle for targeted co-delivery of doxorubicin and Bcl-2 siRNA in breast cancer therapy. Qian J; Xu M; Suo A; Xu W; Liu T; Liu X; Yao Y; Wang H Acta Biomater; 2015 Mar; 15():102-16. PubMed ID: 25545322 [TBL] [Abstract][Full Text] [Related]
7. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance. Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433 [TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy. Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and in vivo evaluation of doxorubicin loaded BSA nanoparticles with folic acid modified dextran surface. Hao H; Ma Q; Huang C; He F; Yao P Int J Pharm; 2013 Feb; 444(1-2):77-84. PubMed ID: 23370437 [TBL] [Abstract][Full Text] [Related]
10. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas. Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518 [TBL] [Abstract][Full Text] [Related]
11. Comb-like amphiphilic polypeptide-based copolymer nanomicelles for co-delivery of doxorubicin and P-gp siRNA into MCF-7 cells. Suo A; Qian J; Zhang Y; Liu R; Xu W; Wang H Mater Sci Eng C Mater Biol Appl; 2016 May; 62():564-73. PubMed ID: 26952460 [TBL] [Abstract][Full Text] [Related]
12. Self-Assembled Cationic Biodegradable Nanoparticles from pH-Responsive Amino-Acid-Based Poly(Ester Urea Urethane)s and Their Application As a Drug Delivery Vehicle. He M; Potuck A; Kohn JC; Fung K; Reinhart-King CA; Chu CC Biomacromolecules; 2016 Feb; 17(2):523-37. PubMed ID: 26650653 [TBL] [Abstract][Full Text] [Related]
13. Delivery of siRNA using folate receptor-targeted pH-sensitive polymeric nanoparticles for rheumatoid arthritis therapy. Sun X; Dong S; Li X; Yu K; Sun F; Lee RJ; Li Y; Teng L Nanomedicine; 2019 Aug; 20():102017. PubMed ID: 31128293 [TBL] [Abstract][Full Text] [Related]
14. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin. Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896 [TBL] [Abstract][Full Text] [Related]
15. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery. Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060 [TBL] [Abstract][Full Text] [Related]
16. Self assembled dual responsive micelles stabilized with protein for co-delivery of drug and siRNA in cancer therapy. Aji Alex MR; Nehate C; Veeranarayanan S; Kumar DS; Kulshreshtha R; Koul V Biomaterials; 2017 Jul; 133():94-106. PubMed ID: 28433941 [TBL] [Abstract][Full Text] [Related]
17. Design and Application of Rolling Circle Amplification for a Tumor-Specific Drug Carrier. Kim JH; Jang M; Kim YJ; Ahn HJ J Med Chem; 2015 Oct; 58(19):7863-73. PubMed ID: 26361253 [TBL] [Abstract][Full Text] [Related]
18. Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: for the potential targeted ovarian cancer gene therapy. Li TS; Yawata T; Honke K Eur J Pharm Sci; 2014 Feb; 52():48-61. PubMed ID: 24178005 [TBL] [Abstract][Full Text] [Related]
19. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059 [TBL] [Abstract][Full Text] [Related]
20. Double-Cross-Linked Hyaluronic Acid Nanoparticles with pH/Reduction Dual-Responsive Triggered Release and pH-Modulated Fluorescence for Folate-Receptor-Mediated Targeting Visualized Chemotherapy. Zhao X; Jia X; Liu L; Zeng J; Tian K; Zhou T; Liu P Biomacromolecules; 2016 Apr; 17(4):1496-505. PubMed ID: 27010934 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]